Both groups of patients, with SLC34A1 or SLC34A3 defects, shared a common biochemical pattern, including elevated 1,25(OH)2D and alkaline phosphatase levels, suppressed parathyroid hormone (PTH), and hypercalciuria. This evidence concerns the gene SLC34A3 and Hypercalciuria.